Zhejiang Boxiao Biopharmaceutical Co., Ltd. is a prominent player in the biopharmaceutical industry, established in August 2020 in Hangzhou, China by a team of experienced pharmaceutical professionals. The company operates with a strategic objective of integrating characteristic raw materials (intermediates) with special preparations, thereby providing diversified services across various therapeutic fields within the pharmaceutical sector.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Contract Manufacturing (CMO/CDMO)
- Development of pharmaceutical formulations
- Production of active pharmaceutical ingredients (APIs)
- Custom synthesis of intermediates

Zhejiang Boxiao Bio-Pharmaceutical Co., Ltd. is committed to becoming one of the most valuable and trustworthy biopharmaceutical companies in China. For further information, please visit bx-biopharm.com.